wellrank.ai

Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

ClaudequalifiedCollected Jun 25, 2026, 13:41 UTC

Verbatim response from Claude

I want to be straightforward with you on this:

Important Context First

The FDA declared the GLP-1 shortage (semaglutide/tirzepatide) officially over in 2024-2025, which means compounding pharmacies must stop producing these drugs. The regulatory situation is actively changing.

Services That Were Known for Compounded GLP-1s

  • Hims & Hers - was offering compounded semaglutide but faced FDA pressure
  • LifeMD/RexMD - similar situation
  • Henry Meds - offered compounded options
  • Mochi Health - focused on GLP-1 prescriptions
  • Calibrate - works with GLP-1 medications

My Honest Recommendation

I'd caution you here because:

  • The legal/regulatory status is changing week to week
  • Services offering compounded semaglutide/tirzepatide may be operating in a legal gray area
  • Quality control of compounded versions varies
  • Some compounds use salt forms (like semaglutide sodium) that the FDA says are not equivalent

Better Path Forward

  • Ask your primary care doctor about brand-name Ozempic/Wegovy/Mounjaro
  • Check manufacturer savings programs (Novo Nordisk, Eli Lilly offer coupons)
  • Look into insurance appeals

Would you like help thinking through accessing the brand-name versions affordably?

Brands mentioned in this answer

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.